Wockhardt Limited (BOM:532300)
India · Delayed Price · Currency is INR 1,906.95
-9.50 (-0.50%)
At close: Jul 30, 2026
Wockhardt Market Cap
Wockhardt has a market cap or net worth of 318.44 billion as of July 31, 2026. Its market cap has increased by 16.32% in one year.
Market Cap
318.44B
Enterprise Value
338.04B
Revenue
34.62B
Ranking
n/a
PE Ratio
149.50
Stock Price
1,906.95
ChartMarket Cap Chart
Since February 21, 2001, Wockhardt's market cap has increased from 17.40B to 318.44B, an increase of 1,729.69%. That is a compound annual growth rate of 12.10%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 318.44B | 35.51% |
| Dec 31, 2025 | 235.00B | 2.08% |
| Dec 31, 2024 | 230.20B | 276.45% |
| Dec 29, 2023 | 61.15B | 90.30% |
| Dec 30, 2022 | 32.13B | -29.77% |
| Dec 31, 2021 | 45.75B | -24.44% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 590.39B |
| GlaxoSmithKline Pharmaceuticals | 449.51B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 245.64B |
| Granules India | 204.20B |
| AstraZeneca Pharma India | 202.59B |
| Caplin Point Laboratories | 191.15B |
| Jubilant Pharmova | 148.07B |